"The life sciences investor manages the holdings of the Novo Nordisk Foundation, the world’s largest philanthropic body. This includes an investment portfolio valued at $24bn in 2022 consisting of life sciences and capital investments, in equities, bonds, real estate and infrastructure, as well as controlling stakes in companies Novo Nordisk and industrial enzymes maker Novozymes."

https://www.ft.com/content/efd96612-3762-4110-a35b-c3ddfc698813